DiaMedica Therapeutics Inc. - Voting Common Shares, no par value (DMAC)
CUSIP: 25253X207
Q3 2020 13F Holders as of 30 Sep 2020
- Type / Class
- Equity / Voting Common Shares, no par value
- Shares outstanding
- 52,272,727
- Total 13F shares
- 6,707,026
- Share change
- +3,672,582
- Total reported value
- $28,383,192
- Price per share
- $4.24
- Number of holders
- 30
- Value change
- +$15,491,837
- Number of buys
- 22
- Number of sells
- 5
Quarterly Holders Quick Answers
What is CUSIP 25253X207?
CUSIP 25253X207 identifies DMAC - DiaMedica Therapeutics Inc. - Voting Common Shares, no par value in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 25253X207:
Top shareholders of DMAC - DiaMedica Therapeutics Inc. - Voting Common Shares, no par value (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| Nantahala Capital Management, LLC |
13F
|
Company |
1.4%
|
750,000
|
$5,198,000 | — | 30 Jun 2020 | |
| Stonepine Capital Management, LLC |
13F
|
Company |
1.3%
|
668,430
|
$4,632,000 | — | 30 Jun 2020 | |
| Granite Point Capital Management, L.P. |
13F
|
Company |
0.91%
|
477,230
|
$3,307,000 | — | 30 Jun 2020 | |
| Manatuck Hill Partners, LLC |
13F
|
Company |
0.67%
|
351,100
|
$2,433,000 | — | 30 Jun 2020 | |
| VANGUARD GROUP INC |
13F
|
Company |
0.46%
|
241,817
|
$1,676,000 | — | 30 Jun 2020 | |
| Corriente Advisors, LLC |
13F
|
Company |
0.38%
|
201,248
|
$1,395,000 | — | 30 Jun 2020 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
0.2%
|
104,700
|
$726,000 | — | 30 Jun 2020 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.18%
|
95,871
|
$664,000 | — | 30 Jun 2020 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.11%
|
56,412
|
$390,000 | — | 30 Jun 2020 | |
| BlackRock Finance, Inc. |
13F
|
Company |
0.09%
|
44,508
|
$309,000 | — | 30 Jun 2020 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.03%
|
13,472
|
$93,000 | — | 30 Jun 2020 | |
| BLAIR WILLIAM & CO/IL |
13F
|
Company |
0.02%
|
10,000
|
$69,000 | — | 30 Jun 2020 | |
| MORGAN STANLEY |
13F
|
Company |
0.01%
|
5,800
|
$41,000 | — | 30 Jun 2020 | |
| Federation Des Caisses Desjardins du Quebec |
13F
|
Individual |
0.01%
|
5,800
|
$40,194 | — | 30 Jun 2020 | |
| American Portfolios Advisors |
13F
|
Company |
0%
|
2,500
|
$17,325 | — | 30 Jun 2020 | |
| ROYAL BANK OF CANADA |
13F
|
Company |
0%
|
2,415
|
$16,000 | — | 30 Jun 2020 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
0%
|
2,000
|
$14,000 | — | 30 Jun 2020 | |
| UBS Group AG |
13F
|
Company |
0%
|
589
|
$4,000 | — | 30 Jun 2020 | |
| BANK OF MONTREAL /CAN/ |
13F
|
Company |
0%
|
310
|
$2,000 | — | 30 Jun 2020 | |
| GABLES CAPITAL MANAGEMENT INC. |
13F
|
Company |
0%
|
125
|
$1,000 | — | 30 Jun 2020 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0%
|
73
|
$1,000 | — | 30 Jun 2020 |
Institutional Holders of DiaMedica Therapeutics Inc. - Voting Common Shares, no par value (DMAC) as of Q3 2020
As of 30 Sep 2020,
DiaMedica Therapeutics Inc. - Voting Common Shares, no par value (DMAC) was held by
30 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
6,707,026 shares.
The largest 10 holders included
Stonepine Capital Management, LLC, Point72 Asset Management, L.P., Nantahala Capital Management, LLC, Corriente Advisors, LLC, Granite Point Capital Management, L.P., Manatuck Hill Partners, LLC, Ikarian Capital, LLC, Maven Securities LTD, VANGUARD GROUP INC, and CVI Holdings, LLC.
This page lists
30
institutional shareholders reporting positions in this security
for the Q3 2020 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q3 2020 vs Q2 2020 Across Filers
Q2 2020 holders
20
Q3 2020 holders
30
Holder diff
10
| Investor | Q2 2020 Shares | Q3 2020 Shares | Share Diff | Share Chg % | Q2 2020 Value $ | Q3 2020 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.